Israel okays plasma-derived drug for compassionate use in corona patients
Kamada releases first batch of its immunoglobulin product for coronavirus disease, plans clinical study on hospitalized patients.
JUNE 22, 2020, 9:40 AM
Abigail Klein Leichman is a writer and associate editor at ISRAEL21c. Prior to moving to Israel in 2007, she was a specialty writer and copy editor at a major daily newspaper in New Jersey and has freelanced for a variety of newspapers and periodicals since 1984.
No hay comentarios:
Publicar un comentario